seed
Stage
1
Investors
About
HydRegen develops bio-based manufacturing technologies that replace toxic metal catalysts in hydrogenation reactions, enabling cleaner, safer, and more sustainable chemical processes. Their biocatalytic systems use hydrogen gas to regenerate cofactors, eliminating waste and improving efficiency in existing manufacturing infrastructure.
Explore HydRegen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.